MK-5720 in people with Schizophrenia (MK-5720-001)
This study evaluated the safety of MK-5720 for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Glendale
Get research updatesSchizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
This study evaluated the safety of MK-5720 for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including GlendaleCONSTATRE: Risperdal Consta Trial Of Relapse Prevention And Effectiveness
This study has finished and is no longer accepting participants.
Multiple locations, including Hall in TirolResearchers compared LY2140023 and Aripiprazole, tracking side effects to assess safety and tolerability in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Garden GroveA Randomized, Double-Blind, Placebo-Controlled Parallel Arm Study of the Effect of RO4917838 on Biomarker Measures of Cognitive Dysfunction in Schizophrenia and Schizoaffective Disorder
This study has finished and is no longer accepting participants.
In OrangeburgA Six-month, Double-blind, Randomized, International, Multicenter Trial to Evaluate the Glucoregulatory Effects of Risperidone and Olanzapine in Subjects With Schizophrenia or Schizoaffective Disorder
This study has finished and is no longer accepting participants.
Location not clearly listedThis study evaluated the safety and effectiveness of Asenapine for people with schizophrenia.
This study has finished and is no longer accepting participants.
Location not clearly listedResearchers compared SEP363856 and quetiapine XR, tracking side effects to assess long-term safety and tolerability in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including CerritosThis study evaluated the safety and effectiveness of SP-624 for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Garden GroveResearchers studied Paliperidone palmitate 3 month formulation (PP3M) to find out how it affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including RijekaThis study has finished and is no longer accepting participants.
In ChangshaA Multicenter Retrospective Study to Analyse the Impact of Treatment With Paliperidone Palmitate on Clinical Outcomes and Hospital Resource Utilization in Adult Patients With Schizophrenia in Portugal
This study has finished and is no longer accepting participants.
In PortoA Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including PhoenixWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.